The Oncology Institute, Inc. (TOI) Misses Q4 EPS by 6c

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q4 EPS of ($0.14), $0.06 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $100.27 million versus the consensus estimate of $109.15 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Baldwin Insurance (BWIN) PT Raised to $25 at BMO Capital
• Klarna (KLAR) PT Raised to $19 at BMO Capital